TXG · 10x Genomics, Inc.
Price
Snapshot
50 fields · last close| Market Cap | $8.51B |
| P/E | — |
| Float | 118.5M |
| Beta | 2.07 |
| Volatility 30D | 107.8% |
| Exchange | NASDAQ |
| Sector | Life Sciences Tools & Services |
| Cap tier | Mid cap |
| Macro sensitivity | Very High |
| Clavix score | 47.2 |
| Price | 58.44 |
| Change | −13.45% |
| Prev Close | 67.52 |
| Open | 68.25 |
| Day Low | 62.88 |
| Day High | 68.32 |
| Avg Vol | 3 |
| Avg $ Vol | $222.9M |
| 52W High | 102.81 |
| 52W Low | 12.80 |
| 52W Pos | 50.7% |
| From High | −43.16% |
| From Low | +356.56% |
| Max DD 1Y | −36.94% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −19.90% |
| SMA 50 | −21.23% |
| SMA 200 | +41.75% |
| RSI (14) | 44.3 |
| Vol 90D | 85.4% |
| Vol 1Y | 76.1% |
| 1Y Range | 13–103 |
| Daily bars | 549 |
| Perf Week | −19.25% |
| Perf Month | −16.29% |
| Perf Quarter | +48.07% |
| Perf Half Y | +196.92% |
| Perf Year | +392.85% |
| Perf YTD | +251.62% |
| Prev Day | −13.45% |
| Clavix | D+ |
| Debt / Eq | 0.04 |
| Curr Ratio | 4.46 |
| Int Cover | -66.1× |
| FCF Margin | 20.2% |
| Rev Growth | +5.2% |
| Profit | Unprofitable |
| Leverage | Low |
| Sector rank | 18 / 19 |
Clavix risk grade
regraded every trading dayTXG grades D+, 47.2 of 100. Steadiest on News Sentiment (67), most exposed on Price Stability (25, weak). 1 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 18 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| TXG | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 2.07 | 1.16 |
| 30-day realized volatilityannualized, from daily closes | 107.8% | 30.3% |
| Max drawdown, past yearworst peak-to-trough fall | −36.9% | — |
| Typical daily movemedian absolute daily change | 2.80% | — |
| Days beyond ±3%of the last 252 sessions | 119 (47%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| TXG | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 2.07 | 1.16 |
| Macro sensitivityrate, dollar and credit exposure bucket | Very High | Moderate 53% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| TXG | |
|---|---|
| 1 week | −19.3% |
| 1 month | −16.3% |
| Year to date | +251.6% |
| 1 year | +392.8% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| TXG | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 2 Sep |
| Average score0 most bearish, 100 most bullish | 66 |
| Bullish · bearisharticles above 60 · below 40 | 24 · 4 |
| Directionarticles whose tone is improving vs worsening | 24 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| TXG | |
|---|---|
| Revenue growthyear over year | +5.2% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to open10x Genomics commercially launched Sentira Single Cell, a cloud-based AI application powered by Anthropic’s Claude that lets researchers analyze Chromium single-cell data through natural-language requests. The company says the product makes advanced single-cell analysis more accessible and accelerates the path from scientific questions to experimental conclusions.
On October 28, 2026, 10x Genomics appointed Ansuman Satpathy and Joseph Gilliam to its board as Class III directors, effective immediately. Their terms last until the company’s 2028 annual meeting or until they leave the board earlier.
Simplify Asset Management reduced its 10x Genomics stake by 76.7% in the third quarter, according to its latest quarterly filing with the SEC. The fund reported holding 68,239 TXG shares after the reduction.
The article says 10x Genomics' share price moved above its 50-day moving average following an analyst downgrade. It provides no analyst name, rating, price target, share-price figures, or supporting details, and does not identify the downgrade as the cause.
10x Genomics told a Delaware federal judge that it will no longer pursue its patent case against Parse Biosciences over methods of analyzing genetic information. The move followed the Federal Circuit’s refusal to revive the three remaining patents in the dispute.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| BRKR | Bruker Corporation | C+ | $9.72B | — | 1.26 | Compare |
| QGEN | QIAGEN N.V. | B+ | $10.50B | 25.58 | 0.57 | Compare |
| AVTR | Avantor, Inc. | B- | $10.60B | — | 0.95 | Compare |
| RGEN | Repligen Corporation | B- | $11.39B | 232.35 | 1.17 | Compare |
| TECH | Bio-Techne Corporation | A | $11.42B | 62.75 | 1.26 | Compare |
| TEM | Tempus AI, Inc. | D- | $13.79B | — | 2.50 | Compare |
| CRL | Charles River Laboratories International, Inc. | B- | $15.58B | — | 1.34 | Compare |
| ADPT | Adaptive Biotechnologies Corporation | C+ | $4.26B | — | 2.17 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.